Aims: To ascertain risk of aneuploidy, infection and neurological abnormality for the fetus diagnosed with isolated mild (10.1-12.0 mm) to moderate (12.1-15.0 mm) cerebral ventriculomegaly and to compare the neurological outcome between symmetrical vs. asymmetrical and stable vs. progressive ventriculomegaly. Methods: A systematic review was conducted. Literature was identified by searching two bibliographical databases between 1980 and 2009 without language restrictions. The data extracted were inspected for heterogeneity. Overall rates and confidence intervals (CIs) for each prognostic factor were calculated. When comparative data existed, the odds ratio (OR) was calculated. Results: The search strategy yielded 2150 relevant citations of which 28 studies were included in the review. The overall rate of infection and chromosomal abnormality was 1.5 and 5% (95% CI 3, 7), respectively. The risk of neurological abnormality regardless of karyotype or infection screen was 14% (95% CI 10, 18) and this reduced to 12% (95% CI 9, 15) when both chromosomes and infection screen were normal. The risk of neurological abnormality was significantly lower in stable compared to progressive ventriculomegaly wOR 0.29 (95% CI 0.15, 0.58)x. No significant differences were detected when symmetrical vs. asymmetrical ventriculomegaly were compared wOR 0.91 (95% CI 0.34, 2.41)x. a Contribution of authorship: P. Devaseelan collected and analysed the data and wrote the manuscript. C. Cardwell contributed to the statistical analysis of the data. B. Bell provided advice on prognostic factors to be evaluated. S. Ong designed the study and contributed to data synthesis and analysis. All authors contributed to the writing of the manuscript. 
Introduction
The width of the fetal cerebral lateral ventricular atrium remains fairly constant at 7.6"0.6 mm at 14-38 weeks' gestation w7x. Ventriculomegaly is defined as dilatation G10 mm of the lateral ventricles w)4 standard deviations (SDs) above the meanx w7x. Several classifications of ventriculomegaly exist. Some authors define ''borderline'' ventriculomegaly as a diameter between 10 and 15 mm w4, 5, 16, 22-25, 41, 43x, whereas others define mild (or ''borderline'') ventriculomegaly as between 10 and 12 mm and moderate ventriculomegaly as between 13 and 15 mm w12, 13, 27x. In any case, a diagnosis of isolated ventriculomegaly between 10 and 15 mm (mild to moderate ventriculomegaly) poses a counselling challenge for the clinician and generates anxiety and uncertainty for the prospective parents.
Perhaps one reason why the diagnosis is such a challenge is that the risk of intrauterine infection, aneuploidy and neurological abnormality are poorly quantified. In addition, there is uncertainty as to how these risks alter in cases of asymmetrical ventriculomegaly or when the condition appears to be progressive w16, 31x.
The purpose of this review is to obtain a more accurate risk estimate to aid the physician in this counselling process. Because of the current different classifications of ventriculomegaly, we have analysed our data of ventriculomegaly of 10.1-15.0 mm, and attempted a sub-analysis of data where ventriculomegaly was between 10.1 and 12.0 mm.
Methods
This systematic review was based on a protocol developed using widely recommended methods for systematic review of observational studies w18, 37x.
The search strategy involved searching the bibliographic databases MEDLINE and EMBASE between 1980 and 2009 inclusive using OVID search software. The search was performed in April of 2009 and included the search terms ''brain ventricular dilatation'', ''ventriculomegaly'' and using a combination of MeSH and text words. Abstracts that met the pre-defined criteria were reviewed by the authors for potential inclusion in the systematic review. The reference lists of included studies were also reviewed for additional relevant studies. No language restriction was applied. Articles in languages other than English were translated by a relevant translator. Our study selection criteria were:
Population
Singleton pregnancy with clear definition of mild to moderate isolated fetal ventriculomegaly (10.1-15.0 mm).
Outcome
Assessment of at least one of the following prognostic factors: chromosomal (abnormal karyotype on invasive testing), infectious (positive TORCH screen), haematological or neurological abnormality (method of diagnosis of neurological abnormality was not specified nor duration of follow-up).
Study design
Prospective and retrospective studies including case series with follow-up of G5 cases. The final inclusion/exclusion decisions were made after evaluation of these criteria by two reviewers (P.D. and S.O.). In cases of data duplication, only the most recent and complete report was included.
One reviewer (P.D.) extracted data from all papers meeting the selection criteria including data on features of methodological quality. This was checked by another reviewer (S.O.). The studies were assessed for quality by the following criteria derived from existing checklists w28x.
Data collection
Prospective collection of data was considered ideal; retrospective collection was considered second best.
Description of population
A well-defined sample with a clear definition of ventriculomegaly (10.1-15.0 mm) and clear documentation of gestational age at diagnosis was considered ideal.
Objective outcome
Clear documentation of at least one of the following prognostic factors: chromosomal abnormality, intrauterine infections, neurological outcome or alloimmune thrombocytopenia were considered ideal.
Prognostic factors considered
Clear documentation of gestational age at delivery, comparison of asymmetrical vs. symmetrical ventriculomegaly or stable vs. progressive ventriculomegaly in terms of neurological outcome or chromosomal or infective status were considered ideal.
Duration of follow-up
Follow-up for at least 2 years after birth was considered ideal.
Outcome ascertainment
Greater than 90% follow-up of the original study population was considered ideal, -90% was considered second best.
Data extraction sought information regarding the overall rate of chromosomal abnormality, infection and neurological abnormality in those fetuses with isolated mild to moderate ventriculomegaly. Information was also sought where there was comparative data between asymmetrical vs. symmetrical and stable vs. progressive ventriculomegaly with regard to neurological outcome, chromosomal abnormality and infective status. A subgroup analysis was also performed for chromosomal abnormality, infection and abnormal neurological outcome for mild ventriculomegaly (10.1-12 mm) where such data were available. Data were extracted to allow computation of odds ratio (OR), stratifying by prognostic factors wherever possible.
The extracted data were tabulated to allow qualitative inspection for clinical and methodological heterogeneity. For comparison of dichotomous outcomes between two groups, ORs and standard errors (SEs) were calculated for the association in each study. The heterogeneity of estimates was explored graphically using forest plots and formally tested using x 2 -tests. The I 2 statistic was also presented where appropriate to quantify the degree of heterogeneity between the studies w40x. Random-effects models were then used to calculate combined estimates w9x allowing for between study heterogeneity. For proportion outcomes, binomial exact 95% confidence intervals (CIs) were presented in forest plots as the numerators for some proportions were small. Heterogeneity was formally tested using x 2 -tests wthe presented P-value was based upon exact Monte Carlo methods, to adjust for any small cell counts, using Statistical Package for Social Services (SPSS)x w35x. A combined proportion was calculated using random effects models on the log odds scale (where the numerator of a proportion was zero, a correction of a half was added to the numerator and denominator to allow analysis to proceed w38x. Data from individual studies were pooled within subgroups defined by prognosis and outcome w8x. Except where noted, the analysis of ORs was conducted using Review Manager 5 w29x and the analysis of proportions was conducted using STATA v9 w36x.
Results
The electronic search yielded a total of 2150 citations, of which 70 were considered potentially relevant. Examination of the full manuscripts revealed that 42 studies did not meet the selection criteria. Thus, a total of 28 primary studies (1496 pregnancies) were selected for review (Figure 1 2, 4-6, 10, 12-17, 19, 20, 22-27, 30, 31, 33, 34, 39, 41-43x . Five studies were prospective w5, 12, 30, 33, 43x and the others were retrospective observational studies. Eleven studies w1, 6, 12, 13, 19, 22, 26, 27, 33, 34, 43x had information on neurological outcome and 10 of these with the exception of the paper by Alagappan et al. w1x looked at chromosomal abnormality for mild ventriculomegaly (10.1-12.0 mm). Eight studies w6, 12, 19, 22, 27, 33, 34, 43x had information on infection screen in mild ventriculomegaly (10.1-12.0 mm). Figure 2 summarises the quality assessment of the studies included in the systematic review. The average gestational age at diagnosis of ventriculomegaly was 25 weeks (range 15-39 weeks). This was reported in 71% (20/28) of studies. All the 28 studies clearly defined ventriculomegaly.
Four objective outcomes that influenced prognosis were considered. A total of 78% (22/28) of the studies reported chromosomal abnormalities, 53% (15/28) reported infections, 89% (25/28) reported on neurological abnormality and only 10% (3/28) reported on alloimmune thrombocytopenia as an outcome (Table 1) . Chromosomal abnormalities were diagnosed by amniocentesis and an infection screen was considered positive by maternal seroconversion on peripheral venous sample, in all papers reviewed. The methods in assessing neurological abnormality varied. In general, neurological abnormality was classified as mild (delayed motor skill, nystagmus, mild speech impairment) or severe (cerebral palsy, urinary incontinence, blindness, mental retardation). Neurological outcome was assessed either singly or by a combination of clinical assessment, telephone questionnaires and scoring systems (Illingworth's Developmental Screening test, Griffith's Scale, Bayley's Developmental Index, etc.). A total of 64% (18/28) had follow-up data for G2 years after birth. The median length of follow-up was 30 months (range 2-72 months).
The paper by Terry et al. w39x describes aneuploidy rates in two different study populations and the data are presented in two separate cohorts (࠻-cohort 1; $-cohort 2).
A total of 75% (21/28) of papers had comparative data between stable vs. progressive ventriculomegaly and 35% (10/28) provided comparison between symmetrical vs. asymmetrical ventriculomegaly.
Overall rates for mild to moderate ventriculomegaly (10.1-15.0 mm)
The overall rate of a positive infection screen when isolated ventriculomegaly was identified was 1.5% (9/586). The overall risk of chromosomal abnormality was 5% (41/923) (95% CI 3, 7). Heterogeneity was evident in these estimates (Ps0.008) (Figure 3) .
The overall risk of neurological abnormality regardless of karyotype or infection status was 14% (155/1147) (95% CI 10, 18); heterogeneity P-0.001) ( Figure 4A ). The overall risk of neurological abnormality when both the chromosomes and infection screen were normal decreased to 12% (48/508) (95% CI 9, 15) and there was less evidence of variation between studies (heterogeneity Ps0.11) ( Figure 4B ). The tools used to assess the severity of neurological abnormality varied widely in individual studies from telephone question- naires to standardised scoring systems making comparisons difficult.
Only three papers reported on alloimmune thrombocytopenia and the overall risk was 4.4% (3/68).
Overall rates for mild ventriculomegaly (10.1-12.0 mm)
In mild ventriculomegaly (10.1-12.0 mm) the overall rate of aneuploidy was 3% (9/310). The overall rate of abnormal neurological outcome was 4% (12/319) ( Figure 5A, B) . Of the eight papers which provided information on abnormal infection screen for mild ventriculomegaly (10.1-12.0 mm), the overall rate was 0.4% (1/235). Because of the small numbers, the CIs and degree of heterogeneity could not be reliably calculated for any of these estimates for ventriculomegaly between 10.1 and 12.0 mm.
Neurological abnormality for mild to moderate ventriculomegaly (10.1-15.0 mm); stable vs. progressive ventriculomegaly
Neurological outcome was compared between stable and progressive ventriculomegaly regardless of their karyotype and infection screen. Data were derived from 10 studies involving 451 pregnancies. The overall risk of neurological sequelae in stable ventriculomegaly was significantly lower when compared to progressive ventriculomegaly wOR: 0.29 (95% CI 0.15, 0.58)x and there was little evidence of heterogeneity between the study estimates wI 2 s0%; Ps0.54x (Figure 6A) .
To assess the risk of neurological abnormality between stable and progressive ventriculomegaly when the chromosomes and infection screen was normal, data were derived from eight studies involving 278 pregnancies. The risk of neurological abnormality was significantly lower in stable when compared to progressive ventriculomegaly wOR: 0.32 (95% CI 0.14, 0.73)x with little heterogeneity wI 2 s0%; Ps0.55x ( Figure 6B ). (I 2 s0%; Ps0.96). With two studies only, this analysis is underpowered. However, these data are presented in Figure  7 along with other studies without comparative data, to illustrate the poor available data.
To assess the risk of neurological abnormality between symmetrical and asymmetrical ventriculomegaly when the chromosomes and infection screen was normal data were derived from two studies involving 180 pregnancies. The risk of neurological sequelae was not statistically different between symmetrical and asymmetrical ventriculomegaly wOR: 1.03 (95% CI 0.39, 2.73); I 2 s0%; Ps0.88x. However, with only two studies, this analysis is again underpowered.
Discussion
This systematic review can provide the physician with some estimates of prognosis. In cases of isolated mild to moderate ventriculomegaly (10.1-15.0 mm), the risk of infection and aneuploidy is 1.5 and 5%, respectively. The overall risk of neurological abnormality for mild to moderate ventriculomegaly is 14%. If an infection screen and chromosomal status are normal, the overall risk of neurological abnormality falls to 12%. This study also confirms that where the condition is progressive, the risk of neurological sequelae increases.
In cases of isolated mild ventriculomegaly (10.1-12.0 mm), the risk of infection and aneuploidy is 0.4 and 3%, respectively. The overall risk of neurological abnormality is 4%. However, these estimates have to be interpreted with caution because of the paucity of data.
The main strength of this review is that it employed an exhaustive research strategy. In this way, we were able to collate evidence from a reasonable number of studies for a condition that is imprecisely assessed in individual studies. In addition, the quality of these studies was assessed together with stratification of results according to the objective outcomes which influenced prognosis.
There are two important limitations to the evaluation of neurological abnormality in this review. The first is the duration of follow-up after birth. The minimum duration of follow-up was not specified at the commencement of this review. The median length of follow-up was 30 months (range 2-72 months). This is important as subtle learning disabilities may not be apparent until after school age. The second limitation is the methods used in assessing neurological outcome. Again, the tools used varied. In general, neurological outcome was assessed either singly or by a combination of clinical assessment, telephone questionnaires and scoring systems. Although there are a number of standardised screening tools, they vary in their sensitivity and specificity.
We were also unable to sub-analyse our data for mild, moderate and severe neurological abnormality. This information could have been useful to aid parental counselling. The paper by Gaglioti et al. w13x provides a clear classifi- cation of mild to moderate/severe neurological impairment but it was not possible to elucidate the same amount of information from other studies. Moreover, it is impossible to ascertain if such disabilities are due to the mild ventriculomegaly per se or are due to other factors. The general prevalence of spontaneous mental disability in children is difficult to estimate but is quoted to be around 2-3% based on population based epidemiological studies w11, 21x. These figures have to be borne in mind when counselling prospective parents who are faced with the possibility of termination of pregnancy.
It was impossible to control for confounding factors like gestational age at delivery, which was poorly reported. Publication bias may also be an issue, although in this instance, it is unlikely that units with poorer outcomes would be less likely to publish their data. It is difficult to quantify the effect of publication bias on this review.
The number of studies which provided comparative data on symmetrical vs. asymmetrical ventriculomegaly were few and hence we were unable to establish whether this is a significant prognostic factor.
Although this study provides some reliable estimates on prognosis, due to paucity of reporting in individual studies, these data cannot reliably guide clinicians regarding management of pregnancy. The decision to offer termination of pregnancy in a fetus with stable isolated ventriculomegaly is a difficult and complex issue w44x. In addition, the timing of delivery if ventriculomegaly progresses in-utero remains unexplored. There is urgent need for large scale prospective data.
One source of bias is that most of the studies in this review were from tertiary units. Some studies incorporated in this review included patients from the late 1970s when the quality of ultrasound machines was poor. Hence, it is possible that mild cases of ventriculomegaly could be underrepresented in this review. Furthermore, the issue of a diagnosis of apparent ''isolated ventriculomegaly'' is pertinent and is another source of bias. For example, agenesis of the corpus callosum was seldom diagnosed antenatally before 1995. This systematic review does not address the current trend for MRI of the fetal brain in isolated mild to moderate ventriculomegaly, where its role remains controversial w3, 32x. Further research might shed light on whether fetal MRI can detect a subgroup of fetuses with apparently isolated ventriculomegaly with underlying occult brain pathology.
